$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Ruxolitinib Cream (Opzelura) Drug Instructions and Correct Usage Analysis
2026-02-01 22:25:32
Check Details
Jisandai (Epclusa/Epclusa) Indian version latest price and purchase channel reference instructions
2026-02-01 22:25:32
Check Details
How much does Sunitinib cost in the Chinese market and its purchase reference
2026-02-01 22:25:32
Check Details
Long-term REACH3 data confirms the efficacy of ruxolitinib tablets/Jakavi in u200bu200bsteroid-refractory cGVHD
2026-02-01 22:25:32
Check Details
Clofazimine latest market price inquiry in 2025
2026-02-01 22:25:32
Check Details
Indian version of Enasidenib price and purchase method
2026-02-01 22:25:32
Check Details
How to buy amivantamab in the country
2026-02-01 22:25:32
Check Details
Enzalutamide/enzalutamide shows higher relative efficacy than darotamide in mHSPC
2026-02-01 22:25:32
Check Details
What is the trade name of Sorafenib and how many types are there on the market?
2026-02-01 22:25:32
Check Details
The launch date of Ruxolitinib Tablets/Gekway
2026-02-01 22:25:32
Check Details
The main side effects and precautions of Clofazimine/Sempra
2026-02-01 22:25:32
Check Details
Is it impossible to stop taking Enasidenib once you take it?
2026-02-01 22:25:32
Check Details
1
2
...
2020
2021
2022
2023
2024
2025
2026
...
10213
10214
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Adagrasib Medication Management Guide for Special Populations
2
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
3
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
4
FDA Approves Dual Immunotherapy Combo: Tecvayli + Darzalex Faspro Transforms RRMM Treatment
5
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
6
Pretomanid for Drug-Resistant TB: Risks and Management of 3-Year Treatment
7
SKYSCRAPER-02C Study: New Hope for Extensive-Stage Small Cell Lung Cancer Treatment
8
LPCAT3: The Key Player in MASH Progression to Hepatocellular Carcinoma
9
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
10
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
11
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
12
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management